- Home
- CARV vs NERV Comparison
CARV vs NERV Comparison
Compare CARV & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- NERV
- Stock Information
- Founded
- CARV 1948
- NERV 2007
- Country
- CARV United States
- NERV United States
- Employees
- CARV N/A
- NERV N/A
- Industry
- CARV Savings Institutions
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- NERV Health Care
- Exchange
- CARV Nasdaq
- NERV Nasdaq
- Market Cap
- CARV 14.5M
- NERV 14.6M
- IPO Year
- CARV 1994
- NERV 2014
- Fundamental
- Price
- CARV $2.74
- NERV $4.23
- Analyst Decision
- CARV
- NERV Hold
- Analyst Count
- CARV 0
- NERV 1
- Target Price
- CARV N/A
- NERV $5.00
- AVG Volume (30 Days)
- CARV 19.7K
- NERV 9.3M
- Earning Date
- CARV 11-13-2025
- NERV 11-05-2025
- Dividend Yield
- CARV N/A
- NERV N/A
- EPS Growth
- CARV N/A
- NERV N/A
- EPS
- CARV N/A
- NERV 1.48
- Revenue
- CARV $22,032,000.00
- NERV N/A
- Revenue This Year
- CARV N/A
- NERV N/A
- Revenue Next Year
- CARV N/A
- NERV N/A
- P/E Ratio
- CARV N/A
- NERV $3.10
- Revenue Growth
- CARV N/A
- NERV N/A
- 52 Week Low
- CARV $1.30
- NERV $1.15
- 52 Week High
- CARV $3.85
- NERV $12.46
- Technical
- Relative Strength Index (RSI)
- CARV 55.29
- NERV 58.36
- Support Level
- CARV $2.66
- NERV $4.27
- Resistance Level
- CARV $2.89
- NERV $12.46
- Average True Range (ATR)
- CARV 0.15
- NERV 0.89
- MACD
- CARV -0.02
- NERV 0.12
- Stochastic Oscillator
- CARV 34.99
- NERV 19.49
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.